cytochrome-c-t and Endomyocardial-Fibrosis

cytochrome-c-t has been researched along with Endomyocardial-Fibrosis* in 2 studies

Other Studies

2 other study(ies) available for cytochrome-c-t and Endomyocardial-Fibrosis

ArticleYear
Beneficial effects of edaravone, a novel antioxidant, in rats with dilated cardiomyopathy.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:9

    Edaravone, a novel antioxidant, acts by trapping hydroxyl radicals, quenching active oxygen and so on. Its cardioprotective activity against experimental autoimmune myocarditis (EAM) was reported. Nevertheless, it remains to be determined whether edaravone protects against cardiac remodelling in dilated cardiomyopathy (DCM). The present study was undertaken to assess whether edaravone attenuates myocardial fibrosis, and examine the effect of edaravone on cardiac function in rats with DCM after EAM. Rat model of EAM was prepared by injection with porcine cardiac myosin 28 days after immunization, we administered edaravone intraperitoneally at 3 and 10 mg/kg/day to rats for 28 days. The results were compared with vehicle-treated rats with DCM. Cardiac function, by haemodynamic and echocardiographic study and histopathology were performed. Left ventricular (LV) expression of NADPH oxidase subunits (p47(phox), p67(phox), gp91(phox) and Nox4), fibrosis markers (TGF-β(1) and OPN), endoplasmic reticulum (ER) stress markers (GRP78 and GADD 153) and apoptosis markers (cytochrome C and caspase-3) were measured by Western blotting. Edaravone-treated DCM rats showed better cardiac function compared with those of the vehicle-treated rats. In addition, LV expressions of NADPH oxidase subunits levels were significantly down-regulated in edaravone-treated rats. Furthermore, the number of collagen-III positive cells in the myocardium of edaravone-treated rats was lower compared with those of the vehicle-treated rats. Our results suggest that edaravone ameliorated the progression of DCM by modulating oxidative and ER stress-mediated myocardial apoptosis and fibrosis.

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyrine; Apoptosis; Autoimmune Diseases; Blotting, Western; Cardiac Myosins; Cardiomyopathy, Dilated; Caspase 3; Cytochromes c; Down-Regulation; Edaravone; Endomyocardial Fibrosis; Endoplasmic Reticulum Stress; Heart Ventricles; In Situ Nick-End Labeling; Male; Myocarditis; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Lew; Swine

2012
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.
    Cardiovascular research, 2010, Mar-01, Volume: 85, Issue:4

    Here we investigated the mechanisms by which cardiovascular CB1 cannabinoid receptors may modulate the cardiac dysfunction, oxidative stress, and interrelated cell death pathways associated with acute/chronic cardiomyopathy induced by the widely used anti-tumour compound doxorubicin (DOX).. Both load-dependent and -independent indices of left-ventricular function were measured by the Millar pressure-volume conductance system. Mitogen-activated protein kinase (MAPK) activation, cell-death markers, and oxidative/nitrosative stress were measured by molecular biology/biochemical methods and flow cytometry. DOX induced left-ventricular dysfunction, oxidative/nitrosative stress coupled with impaired antioxidant defense, activation of MAPK (p38 and JNK), and cell death and/or fibrosis in hearts of wide-type mice (CB1(+/+)), and these effects were markedly attenuated in CB1 knockouts (CB1(-/-)). In human primary cardiomyocytes expressing CB1 receptors (demonstrated by RT-PCR, western immunoblot, and flow cytometry) DOX, likewise the CB1 receptor agonist HU210 and the endocannabinoid anandamide (AEA), induced MAPK activation and cell death. The DOX-induced MAPK activation and cell death were significantly enhanced when DOX was co-administered with CB1 agonists AEA or HU210. Remarkably, cell death and MAPK activation induced by AEA, HU210, and DOX +/- AEA/HU210 were largely attenuated by either CB1 antagonists (rimonabant and AM281) or by inhibitors of p38 and JNK MAPKs. Furthermore, AEA or HU210 in primary human cardiomyocytes triggered increased reactive oxygen species generation.. CB1 activation in cardiomyocytes may amplify the reactive oxygen/nitrogen species-MAPK activation-cell death pathway in pathological conditions when the endocannabinoid synthetic or metabolic pathways are dysregulated by excessive inflammation and/or oxidative/nitrosative stress, which may contribute to the pathophysiology of various cardiovascular diseases.

    Topics: Amidohydrolases; Animals; Antibiotics, Antineoplastic; Apoptosis; Cannabinoid Receptor Modulators; Cardiomyopathies; Caspase 3; Caspase 7; Cells, Cultured; Cytochromes c; Disease Models, Animal; Doxorubicin; Endomyocardial Fibrosis; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Myocytes, Cardiac; Oxidative Stress; Poly(ADP-ribose) Polymerases; Reactive Nitrogen Species; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Ventricular Function, Left

2010